Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data
-
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™
-
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
-
PRISM MarketView Joins ThinkEquity Conference as Official Media Sponsor
-
PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis
-
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
-
Aclarion Added to PRISM Emerging Medical Devices Index
-
PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology
-
PRISM MarketView Launches AI Infrastructure and Datacenter Index
-
PRISM MarketView Examines Airline Industry Policies, Financial Reports and Consumer Trends